Journey Medical (DERM)

Journey Medical on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.

Download CSV

3.0M

Short interest

settlement 2026-10-15

16.6

Days to cover

+2.7 days vs prior

48.4%

Short share of volume

2026-11-02

579

Fails to deliver

settlement 2026-10-05

Wed 11 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in DERM is 2,987,988 shares, up 60,474 shares over the last month. Over the last 48 readings it ranged from 60,749 shares (31 October 2024) to 3,718,696 shares (15 April 2026). At the reported average volume of 180K shares a day that is 16.6 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/derm" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	2,987,988	-2.2%	180,196	16.58
2026-09-30	3,055,846	+4.4%	219,731	13.91
2026-09-15	2,927,514	-1.1%	130,023	22.52
2026-08-31	2,961,399	+1.5%	169,699	17.45
2026-08-14	2,917,410	+1.5%	280,041	10.42
2026-07-31	2,874,752	-5.8%	140,066	20.52
2026-07-15	3,052,065	+2.0%	160,958	18.96
2026-06-30	2,990,671	-14.9%	566,775	5.28
2026-06-15	3,515,425	+0.0%	167,828	20.95
2026-05-29	3,514,547	+1.4%	247,363	14.21
2026-05-15	3,467,690	-5.6%	304,396	11.39
2026-04-30	3,674,135	-1.2%	176,901	20.77
2026-04-15	3,718,696	+7.6%	200,251	18.57
2026-03-31	3,456,540	+31.3%	477,090	7.25
2026-03-13	2,632,191	+3.4%	84,964	30.98
2026-02-27	2,544,646	-1.1%	122,387	20.79
2026-02-13	2,573,907	+0.6%	98,003	26.26
2026-01-30	2,559,784	+3.0%	159,585	16.04
2026-01-15	2,483,984	+1.6%	115,523	21.50
2025-12-31	2,444,447	+0.7%	136,310	17.93
2025-12-15	2,427,772	+1.6%	151,576	16.02
2025-11-28	2,390,197	+1.3%	129,398	18.47
2025-11-14	2,358,864	+14.0%	305,351	7.73
2025-10-31	2,069,170	+17.1%	181,740	11.39
2025-10-15	1,767,509	+11.9%	142,243	12.43
2025-09-30	1,578,826	+4.8%	82,836	19.06
2025-09-15	1,506,808	+7.6%	152,559	9.88
2025-08-29	1,399,834	-3.1%	135,937	10.30
2025-08-15	1,445,130	+19.6%	244,311	5.92
2025-07-31	1,208,212	+8.4%	98,706	12.24
2025-07-15	1,114,431	+13.2%	142,691	7.81
2025-06-30	984,153	+79.1%	255,353	3.85
2025-06-13	549,561	+39.6%	106,329	5.17
2025-05-30	393,717	+24.6%	96,527	4.08
2025-05-15	315,981	-4.9%	101,359	3.12
2025-04-30	332,392	+31.8%	86,696	3.83
2025-04-15	252,109	+68.0%	120,855	2.09
2025-03-31	150,053	+27.9%	72,083	2.08
2025-03-14	117,326	+3.4%	53,492	2.19
2025-02-28	113,437	+20.6%	46,128	2.46
2025-02-14	94,090	+12.3%	66,857	1.41
2025-01-31	83,813	+6.5%	44,457	1.89
2025-01-15	78,736	+2.6%	59,436	1.32
2024-12-31	76,766	+14.7%	63,646	1.21
2024-12-13	66,932	-12.8%	135,368	1.00
2024-11-29	76,739	+15.9%	88,047	1.00
2024-11-15	66,232	+9.0%	195,976	1.00
2024-10-31	60,749	-20.8%	95,079	1.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of DERM volume is 48.4%, up 8.7 points over the last five sessions. Over the last 30 readings it ranged from 10.8% (12 October 2026) to 63.3% (23 October 2026). The latest reading is 9.3 points above the 30-session average of 39.1%, on 62K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	30K	62K	48.4%	0
2026-10-30	45K	118K	38.6%	864
2026-10-29	52K	111K	46.9%	0
2026-10-28	42K	85K	49.7%	0
2026-10-27	28K	99K	28.9%	0
2026-10-26	18K	45K	39.7%	0
2026-10-23	41K	65K	63.3%	973
2026-10-22	42K	81K	51.8%	0
2026-10-21	37K	83K	45.1%	0
2026-10-20	36K	85K	42.5%	0
2026-10-19	24K	129K	18.9%	0
2026-10-16	47K	87K	54.6%	0
2026-10-15	29K	90K	32.3%	0
2026-10-14	35K	92K	37.6%	0
2026-10-13	14K	66K	20.6%	0
2026-10-12	17K	157K	10.8%	0
2026-10-09	26K	65K	40.5%	0
2026-10-08	24K	96K	25.1%	0
2026-10-07	45K	109K	41.4%	0
2026-10-06	37K	87K	43.1%	0
2026-10-05	14K	26K	53.4%	0
2026-10-02	33K	60K	54.9%	0
2026-10-01	15K	40K	36.8%	1
2026-09-30	27K	73K	37.5%	291
2026-09-29	10K	25K	41.7%	0
2026-09-28	20K	69K	28.5%	0
2026-09-25	48K	97K	49.4%	0
2026-09-24	30K	125K	23.9%	3,360
2026-09-23	56K	159K	35.1%	944
2026-09-22	33K	103K	32.7%	0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 5 October 2026, the fails-to-deliver balance in DERM is 579 shares, up 469 shares over the last settlement date. Over the last 30 readings it ranged from 39 shares (11 August 2026) to 88,907 shares (1 July 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-05	579	$6.61	$4K
2026-10-02	110	$6.72	$739
2026-09-25	16,031	$6.32	$101K
2026-09-17	200	$7.29	$1K
2026-09-15	476	$7.38	$4K
2026-09-14	5,471	$7.23	$40K
2026-09-11	3,287	$7.09	$23K
2026-09-10	2,617	$7.45	$19K
2026-09-09	4,314	$7.97	$34K
2026-09-08	3,440	$7.86	$27K
2026-09-01	2,145	$7.41	$16K
2026-08-31	1,934	$7.47	$14K
2026-08-24	336	$7.75	$3K
2026-08-21	13,648	$7.49	$102K
2026-08-20	1,445	$6.81	$10K
2026-08-19	375	$6.66	$2K
2026-08-11	39	$6.44	$251
2026-08-10	262	$6.43	$2K
2026-08-05	923	$6.40	$6K
2026-07-21	709	$7.09	$5K
2026-07-14	3,515	$6.86	$24K
2026-07-09	356	$6.68	$2K
2026-07-07	4,291	$7.22	$31K
2026-07-02	148	$7.04	$1K
2026-07-01	88,907	$7.08	$629K
2026-06-30	19,052	$6.79	$129K
2026-06-29	79,619	$6.62	$527K
2026-06-26	2,767	$6.22	$17K
2026-06-25	59,459	$6.85	$407K
2026-06-24	61,083	$6.70	$409K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for DERM in the last 90 days. The most recent filings are listed below. Latest filing: Toledano Miranda Jayne (Director) on 2026-07-01.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-07-01	Toledano Miranda Jayne	Director	Grant	50K	$0.00	$0	169K
2026-07-01	Smith Justin Adam	Director	Grant	50K	$0.00	$0	232K
2026-07-01	Herskowitz Neil	Director	Grant	50K	$0.00	$0	169K
2026-06-25	ROSENWALD LINDSAY A MD	Director	Grant	10K	$0.00	$0	221K
2026-06-25	Pearce Michael Cooper	Director	Grant	10K	$0.00	$0	67K
2026-06-25	Herskowitz Neil	Director	Grant	10K	$0.00	$0	119K
2026-06-25	Smith Justin Adam	Director	Grant	10K	$0.00	$0	182K
2026-06-25	Toledano Miranda Jayne	Director	Grant	10K	$0.00	$0	119K
2026-04-22	Maraoui Claude	President & CEO	Grant	49K	$0.00	$0	2.4M
2026-04-22	Benesch Joseph	CFO	Grant	29K	$0.00	$0	261K
2026-04-22	Alloush Ramsey	Chief Operating Officer	Grant	47K	$0.00	$0	599K
2025-08-25	Maraoui Claude	President & CEO	Tax withholding	11K	$7.47	$81K	2.4M
2025-08-25	Maraoui Claude	President & CEO	Exercise or conversion	1.3M	$0.07	$81K	2.4M
2025-08-05	ROSENWALD LINDSAY A MD	Director	Grant	50K	$0.00	$0	211K
2025-08-05	Smith Justin Adam	Director	Grant	20K	$0.00	$0	172K
2025-08-05	Toledano Miranda Jayne	Director	Grant	20K	$0.00	$0	109K
2025-08-05	Pearce Michael Cooper	Director	Grant	20K	$0.00	$0	57K
2025-08-05	Herskowitz Neil	Director	Grant	20K	$0.00	$0	109K
2025-06-25	Toledano Miranda Jayne	Director	Grant	7K	$0.00	$0	89K
2025-06-25	ROSENWALD LINDSAY A MD	Director	Grant	7K	$0.00	$0	161K
2025-06-25	Pearce Michael Cooper	Director	Grant	7K	$0.00	$0	37K
2025-06-25	Smith Justin Adam	Director	Grant	7K	$0.00	$0	152K
2025-06-25	Herskowitz Neil	Director	Grant	7K	$0.00	$0	89K
2025-06-17	Maraoui Claude	President & CEO	Grant	49K	$0.00	$0	2.4M
2025-06-17	Benesch Joseph	CFO	Grant	29K	$0.00	$0	232K
2025-06-17	Alloush Ramsey	Chief Operating Officer	Grant	47K	$0.00	$0	552K
2025-05-02	Alloush Ramsey	COO	Sell	3K	$6.84	$20K	505K
2025-05-02	Benesch Joseph	CFO	Sell	2K	$6.84	$16K	204K
2025-05-02	Maraoui Claude	President & CEO	Sell	5K	$6.84	$33K	2.3M
2025-03-11	Maraoui Claude	President & CEO	Sell	49K	$5.01	$247K	2.0M
2025-03-07	Maraoui Claude	President & CEO	Sell	15K	$5.01	$75K	2.1M
2025-03-06	Maraoui Claude	President & CEO	Sell	26K	$5.04	$129K	2.1M
2025-03-05	Maraoui Claude	President & CEO	Sell	18K	$5.13	$93K	2.1M
2025-03-04	Maraoui Claude	President & CEO	Sell	29K	$5.04	$146K	2.1M
2025-03-03	Maraoui Claude	President & CEO	Sell	24K	$5.19	$122K	2.1M
2025-02-21	Benesch Joseph	CFO	Sell	1K	$5.19	$7K	46K
2024-08-01	Benesch Joseph	CFO	Sell	9K	$5.47	$51K	47K
2024-07-23	Benesch Joseph	CFO	Sell	4K	$5.40	$22K	57K
2024-07-19	Pearce Michael Cooper	Director	Grant	30K	$0.00	$0	30K
2024-07-08	ROSENWALD LINDSAY A MD	Director	Grant	10K	$0.00	$0	154K
2024-07-08	Toledano Miranda Jayne	Director	Grant	10K	$0.00	$0	81K
2024-07-08	Herskowitz Neil	Director	Grant	10K	$0.00	$0	81K
2024-07-08	Smith Justin Adam	Director	Grant	10K	$0.00	$0	144K
2024-05-01	Benesch Joseph	CFO	Grant	80K	$0.00	$0	206K
2024-05-01	Maraoui Claude	President & CEO	Grant	175K	$0.00	$0	2.4M
2024-03-25	ROSENWALD LINDSAY A MD	Director	Buy	10K	$3.04	$30K	144K
2024-03-22	ROSENWALD LINDSAY A MD	Director	Buy	20K	$3.40	$68K	134K
2024-03-22	Smith Justin Adam	Director	Buy	30K	$3.47	$104K	135K
2024-03-22	Maraoui Claude	President & CEO	Buy	10K	$3.48	$35K	2.2M
2024-02-22	Benesch Joseph	Interim CFO	Sell	2K	$3.75	$9K	61K
2024-01-03	Benesch Joseph	CFO	Grant	80K	$0.00	$0	126K
2024-01-03	Maraoui Claude	President & CEO	Grant	175K	$0.00	$0	2.2M
2023-11-28	Paley Jeffrey	Director	Sell	2K	$5.22	$9K	71K
2023-11-08	Paley Jeffrey	Director	Sell	255	$3.76	$959	114K
2023-11-07	Paley Jeffrey	Director	Sell	2K	$3.48	$8K	114K
2023-10-13	Smith Justin Adam	Director	Buy	33K	$2.98	$98K	105K
2023-10-06	Paley Jeffrey	Director	Buy	15K	$2.98	$45K	72K
2023-09-21	Paley Jeffrey	Director	Buy	30K	$2.97	$89K	57K
2023-09-06	ROSENWALD LINDSAY A MD	Director	Buy	100K	$2.23	$223K	114K
2023-09-06	Maraoui Claude	President & CEO	Buy	26K	$2.52	$66K	2.2M
2023-07-24	Benesch Joseph	See Remarks	Sell	4K	$1.76	$7K	63K
2023-07-24	Maraoui Claude	President & CEO	Sell	21K	$1.76	$37K	2.1M
2023-07-21	Toledano Miranda Jayne	Director	Grant	27K	$0.00	$0	72K
2023-07-21	Smith Justin Adam	Director	Grant	27K	$0.00	$0	72K
2023-07-21	Paley Jeffrey	Director	Grant	27K	$0.00	$0	72K
2023-07-21	Herskowitz Neil	Director	Grant	27K	$0.00	$0	72K
2023-05-17	Maraoui Claude	President & CEO	Sell	24K	$1.34	$33K	2.1M
2023-05-16	Maraoui Claude	President & CEO	Sell	20K	$1.25	$25K	2.2M
2023-05-12	Fortress Biotech, Inc.	TenPercentOwner	Other transaction	50K	$0.00	$0	3.9M
2023-02-22	Benesch Joseph	Interim CFO	Sell	3K	$1.97	$5K	67K
2023-02-12	Fortress Biotech, Inc.	TenPercentOwner	Other transaction	50K	$0.00	$0	3.9M
2022-11-12	Fortress Biotech, Inc.	TenPercentOwner	Other transaction	50K	$0.00	$0	4.0M
2022-10-04	De Paolantonio Ernest Robert	Chief Financial Officer	Sell	10K	$2.41	$24K	260K
2022-08-12	Fortress Biotech, Inc.	TenPercentOwner	Other transaction	50K	$0.00	$0	4.0M
2022-07-21	De Paolantonio Ernest Robert	Chief Financial Officer	Grant	150K	$0.00	$0	270K
2022-07-21	Maraoui Claude	President & CEO	Grant	300K	$0.00	$0	2.2M
2022-07-21	Toledano Miranda Jayne	Director	Grant	14K	$0.00	$0	44K
2022-07-21	Herskowitz Neil	Director	Grant	14K	$0.00	$0	44K
2022-07-21	Paley Jeffrey	Director	Grant	14K	$0.00	$0	44K
2022-07-21	Smith Justin Adam	Director	Grant	14K	$0.00	$0	44K
2022-07-21	ROSENWALD LINDSAY A MD	Director	Grant	14K	$0.00	$0	14K
2022-05-12	Fortress Biotech, Inc.	TenPercentOwner	Other transaction	50K	$0.00	$0	4.1M
2022-01-14	De Paolantonio Ernest Robert	Chief Financial Officer	Grant	120K	$0.00	$0	120K
2022-01-14	Herskowitz Neil	Director	Grant	30K	$0.00	$0	30K
2022-01-14	Smith Justin Adam	Director	Grant	30K	$0.00	$0	30K
2022-01-14	Paley Jeffrey	Director	Grant	30K	$0.00	$0	30K
2022-01-14	Toledano Miranda Jayne	Director	Grant	30K	$0.00	$0	30K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

1 holder reports 5% or more of DERM in its latest filing, on Schedule 13G (passive). The holder is Wasatch Advisors LP at 11.0% of the class (2,449,253 shares), filed 2026-10-09 for an event on 2026-09-30.

Filed	Form	Holder	Shares	Of class	Event
2026-10-09	13G/Ano. 4	Wasatch Advisors LPinvestment adviser	2.4M	11.0%	2026-09-30
2026-07-31	13G/Ano. 1	Vanguard Capital Managementinvestment adviser	775K	3.6%	2026-06-30

13F holders

Tracked managers holding DERM at their latest 13F. JSON

4 of the 30 tracked managers held DERM at their latest 13F, $3.2M in total at quarter-end prices. Renaissance Technologies is the largest at $1.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Renaissance Technologies	2026-06-30	230K	$1.6M	0.00%	-13K
Millennium Management	2026-06-30	110K	$779K	0.00%	-273K
Citadel Advisors	2026-06-30	82K	$582K	0.00%	new
AQR Capital Management	2026-06-30	25K	$176K	0.00%	new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Journey Medical in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Journey Medical (DERM), SEC CIK 1867066, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-05.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-09.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-01.JSON and CSV
Company record: EDGAR filing index for CIK 1867066Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as pharmaceutical preparations

Other company pages

Datasets

Frequently Asked Questions

How much of DERM is sold short?

2,987,988 shares were held short at the 2026-10-15 settlement, 16.6 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is DERM's daily short volume?

On 2026-11-02, 30,141 of the 62,207 DERM shares reported to FINRA were sold short, 48.4% of the day's reported volume. Short volume is a flow for one day, not a position.

Does DERM have fails to deliver?

The SEC's latest file shows 579 DERM shares failed to deliver at settlement 2026-10-05. Fails are reported per settlement date and published twice a month with a lag.

Are DERM insiders buying or selling?

No open-market insider trades were reported for DERM in the last 90 days. The most recent filings are listed below. Latest filing: Toledano Miranda Jayne (Director) on 2026-07-01.

Who owns 5% or more of DERM?

Which tracked 13F managers own DERM?

4 of the 30 tracked 13F managers held DERM shares at their latest filing, $3.2M in all. The largest: Renaissance Technologies (230K shares, $1.6M), Izzy Englander's Millennium Management (110K shares, $779K), Ken Griffin's Citadel Advisors (82K shares, $582K), Cliff Asness's AQR Capital Management (25K shares, $176K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.